BamSEC and AlphaSense Join Forces
Learn More

Karyopharm Therapeutics Inc.

NASDAQ: KPTI    
Share price (1/8/25): $0.72    
Market cap (1/8/25): $89.7 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 30 pages Form of Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56
EX-4.1
from 8-K 308 pages Karyopharm Therapeutics Inc., as Issuer the Guarantors Party Hereto, and Wilmington Savings Fund Society, Fsb, as Trustee and Collateral Agent Indenture Dated as of May 13, 2024 6.00% Convertible Senior Notes Due 2029
12/34/56
EX-4.1
from 10-Q 18 pages Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3 61 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 59 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 16 pages Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56
EX-4.3
from 10-K 3 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 61 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 59 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.4
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.1
from 8-K 114 pages Karyopharm Therapeutics Inc., as Issuer and Wilmington Trust, National Association, as Trustee Indenture Dated as of October 16, 2018 3.00% Convertible Senior Notes Due 2025
12/34/56
EX-4.4
from S-3ASR 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3ASR 8 pages Form of Senior Note
12/34/56
EX-4.2
from S-3ASR 61 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3ASR 59 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56